Conjugated estrogens / medroxyprogesterone Drug Interactions
A total of 324 drugs are known to interact with conjugated estrogens / medroxyprogesterone.
- 26 major drug interactions
- 269 moderate drug interactions
- 29 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for conjugated estrogens / medroxyprogesterone and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Ambien (zolpidem)
- Armour Thyroid (thyroid desiccated)
- Celexa (citalopram)
- Cymbalta (duloxetine)
- Lamictal (lamotrigine)
- Lasix (furosemide)
- Lunesta (eszopiclone)
- Lyrica (pregabalin)
- medroxyprogesterone (Depo-Provera, Provera, Depo-Provera Contraceptive, depo-subQ provera 104, Amen, Curretab, Cycrin)
- Paracetamol (acetaminophen)
- Percocet (acetaminophen / oxycodone)
- Plavix (clopidogrel)
- Sinemet (carbidopa / levodopa)
- Synthroid (levothyroxine)
- Topamax (topiramate)
- TriCor (fenofibrate)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Zetia (ezetimibe)
Conjugated estrogens / medroxyprogesterone alcohol/food interactions
There are 6 alcohol/food interactions with conjugated estrogens / medroxyprogesterone
Conjugated estrogens / medroxyprogesterone disease interactions
There are 25 disease interactions with conjugated estrogens / medroxyprogesterone which include:
- abnormal genital bleeding
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- bone mineral density
- menstrual bleeding
- breast malignancy
- liver disease
- thromboembolism
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- hyperlipidemia
- weight gain
More about conjugated estrogens/medroxyprogesterone
- Side Effects
- During Pregnancy
- Dosage Information
- En Español
- 25 Reviews
- Drug class: sex hormone combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
